Plan: OPEN | Option: Growth | V Srivatsa

21 Jan 21 | 12:00 AM

140.53 -2.39 (-1.68%)

  • Outperforms

    59.08%

    Return (1Y)

    beaten S&P BSE Healthcare TRI by 5.63%

  • Less Volatile

    1.60%

    Standard Deviation (1Y)

    Lower Equity - Pharma by -0.49%

  • Not so consistent

    6/12

    Months

    Has beaten Equity - Pharma

  • Value research rating

    Not Rated

Stock Composition

NAV

Scheme Trivia

  • UTI-Pharma & Healthcare Fund (G) fund has been the 6th best in 5Y performance in the Equity - Pharma category

  • UTI-Pharma & Healthcare Fund (G) fund has been given the 5th best Risk adjusted performance for the past 5Y in the Equity - Pharma category

  • UTI-Pharma & Healthcare Fund (G) fund has been the 5th best in the 5Y SIP performance in the Equity - Pharma category

Critical Parameters

Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.

Returns

In last 1 year UTI-Healthcare Fund (G), has beaten by 5.63% (CAGR difference)

59.08%

Outperforms

This is Alpha

Performance Chart for Rs

Invested in

Risk

In last 1 year , the volatility of UTI-Healthcare Fund (G) is Lower than by -0.49%

1.60%

Less Volatile

Risk Meter

Peer Comparison on Risk - Return

Consistency

For 6 out of Last 12 Months, i.e 50% of the times It beaten its benchmark, Equity - Pharma

Consistency Meter

Outperforming Stocks Vs. Underperforming Stocks

Based on the last 1year analysis, currently there are, the benchmark the benchmark

View Stock Composition